Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,044 | 446 | 94.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $254.25 | 13 | 3.4% |
| Education | $95.10 | 2 | 1.3% |
| Gift | $52.87 | 3 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $640.30 | 31 | $0 (2020) |
| EMD Serono, Inc. | $524.36 | 40 | $0 (2019) |
| GENZYME CORPORATION | $500.47 | 23 | $0 (2019) |
| ACADIA Pharmaceuticals Inc | $435.51 | 37 | $0 (2020) |
| Biogen, Inc. | $393.08 | 37 | $0 (2019) |
| Genentech USA, Inc. | $357.07 | 16 | $0 (2020) |
| Allergan, Inc. | $339.26 | 22 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $339.02 | 29 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $307.80 | 20 | $0 (2019) |
| Acorda Therapeutics, Inc | $266.38 | 14 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.08 | 1 | Celgene Corporation ($17.08) |
| 2020 | $310.18 | 16 | Harmony Biosciences LLC ($42.27) |
| 2019 | $2,251 | 142 | EMD Serono, Inc. ($372.89) |
| 2018 | $2,573 | 160 | Teva Pharmaceuticals USA, Inc. ($336.59) |
| 2017 | $2,296 | 145 | GENZYME CORPORATION ($263.54) |
All Payment Transactions
464 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/24/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.08 | General |
| Category: Neuroscience | ||||||
| 05/28/2020 | Medtronic USA, Inc. | ACTIVA (Device) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 04/23/2020 | Zyla Life Sciences, Inc. | SPRIX (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Pain Medicine | ||||||
| 02/19/2020 | Medtronic USA, Inc. | ACTIVA (Device) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 02/18/2020 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/15/2020 | Harmony Biosciences LLC | Wakix (Drug) | Food and Beverage | Cash or cash equivalent | $20.81 | General |
| Category: Neurological Disorders | ||||||
| 02/14/2020 | Genentech USA, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Immunology | ||||||
| 02/03/2020 | US WorldMeds, LLC | APOKYN (Drug), Xadago, MYOBLOC | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Neurology | ||||||
| 02/03/2020 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $31.09 | General |
| Category: Central Nervous System | ||||||
| 01/22/2020 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: Neurology | ||||||
| 01/21/2020 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 01/20/2020 | Harmony Biosciences LLC | Wakix (Drug) | Food and Beverage | Cash or cash equivalent | $21.46 | General |
| Category: Neurological Disorders | ||||||
| 01/13/2020 | Endo Pharmaceuticals Inc. | NASCOBAL (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: PRESCRIPTION SUPPLEMENT | ||||||
| 01/08/2020 | US WorldMeds, LLC | APOKYN (Drug), Xadago | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Neurology | ||||||
| 01/07/2020 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Genetic Disease | ||||||
| 12/18/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: HYPERHYDROSIS | ||||||
| 12/17/2019 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: NEUROLOGY | ||||||
| 12/16/2019 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $19.84 | General |
| Category: PARKINSONS DISEASE | ||||||
| 12/13/2019 | Akcea Therapeutics, Inc. | TEGSEDI (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/04/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $0.45 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/27/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: CNS | ||||||
| 11/26/2019 | Medtronic USA, Inc. | ACTIVA (Device) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Deep Brain Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 548 | 711 | $128,062 | $54,110 |
| 2022 | 16 | 631 | 801 | $146,231 | $62,695 |
| 2021 | 14 | 438 | 529 | $107,100 | $44,066 |
| 2020 | 12 | 406 | 516 | $104,311 | $34,559 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 141 | 173 | $19,590 | $12,299 | 62.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 93 | 97 | $20,180 | $9,990 | 49.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 47 | 106 | $12,650 | $6,667 | 52.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 75 | 133 | $22,906 | $5,820 | 25.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $9,016 | $5,175 | 57.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 34 | $5,387 | $3,658 | 67.9% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 13 | 20 | $12,765 | $3,126 | 24.5% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 21 | 21 | $7,022 | $1,707 | 24.3% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 15 | 15 | $6,172 | $1,707 | 27.7% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 11 | 11 | $4,881 | $1,656 | 33.9% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 18 | 18 | $4,428 | $1,210 | 27.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 16 | 16 | $1,360 | $710.88 | 52.3% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 11 | 11 | $1,705 | $384.12 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 164 | 216 | $23,345 | $15,753 | 67.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 73 | 78 | $14,055 | $8,501 | 60.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 76 | 76 | $11,244 | $7,037 | 62.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 78 | 145 | $24,302 | $5,401 | 22.2% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 16 | 27 | $17,350 | $4,603 | 26.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 35 | 43 | $7,040 | $4,409 | 62.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 35 | 61 | $6,710 | $3,531 | 52.6% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 31 | 31 | $12,716 | $3,195 | 25.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $6,120 | $2,752 | 45.0% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 20 | 21 | $3,885 | $2,258 | 58.1% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 11 | 11 | $5,533 | $1,385 | 25.0% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 17 | 17 | $4,238 | $1,083 | 25.5% |
About Dr. Amer Aboukasm, MD
Dr. Amer Aboukasm, MD is a Sleep Medicine healthcare provider based in Detroit, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194754085.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amer Aboukasm, MD has received a total of $7,447 in payments from pharmaceutical and medical device companies, with $17.08 received in 2024. These payments were reported across 464 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($7,044).
As a Medicare-enrolled provider, Aboukasm has provided services to 2,023 Medicare beneficiaries, totaling 2,557 services with total Medicare billing of $195,430. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Sleep Medicine
- Other Specialties Neurology
- Location Detroit, MI
- Active Since 07/02/2006
- Last Updated 05/13/2020
- Taxonomy Code 207RS0012X
- Entity Type Individual
- NPI Number 1194754085
Products in Payments
- NUPLAZID (Drug) $435.51
- Mavenclad (Biological) $318.42
- APTIOM (Drug) $307.80
- TYSABRI (Biological) $294.62
- OCREVUS (Biological) $261.65
- LEMTRADA (Drug) $261.31
- NUEDEXTA (Drug) $258.76
- Equetro (Drug) $253.03
- TROKENDI XR (Drug) $223.96
- AUBAGIO (Drug) $219.97
- Fycompa (Drug) $213.00
- Rebif (Biological) $205.94
- Aimovig (Biological) $186.30
- AUSTEDO (Drug) $175.52
- COPAXONE (Drug) $173.80
- Duopa (Drug) $171.30
- Briviact (Drug) $167.87
- AMPYRA (Drug) $158.73
- RYTARY (Drug) $149.93
- GILENYA (Drug) $141.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sleep Medicine Doctors in Detroit
Andrea Plawecki, M.d, M.D
Sleep Medicine — Payments: $2,175
Dr. Hassan Makki
Sleep Medicine — Payments: $625.04
Mr. Matthew Floyd, Oms 4, OMS 4
Sleep Medicine — Payments: $603.88
Dr. Jovica Veljanovski, M.d, M.D
Sleep Medicine — Payments: $488.56
Dr. Ruth Barnett, D.o, D.O
Sleep Medicine — Payments: $141.08
Dr. Christopher Drake, Ph.d, PH.D
Sleep Medicine — Payments: $37.44